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application of the RE-AIM tool to the field of
housing improvement
Hilary J Thomson* and Sian ThomasAbstract
Background: Researchers and publishers have called for improved reporting of external validity items and for
testing of existing tools designed to assess reporting of items relevant to external validity. Few tools are available
and most of this work has been done within the field of health promotion.
Methods: We tested a tool assessing reporting of external validity items which was developed by Green & Glasgow
on 39 studies assessing the health impacts of housing improvement. The tool was adapted to the topic area and
criteria were developed to define the level of reporting, e.g. “some extent”. Each study was assessed by two
reviewers.
Results: The tool was applicable to the studies but some items required considerable editing to facilitate
agreement between the two reviewers. Levels of reporting of the 17 external validity items were low (mean 6).
The most commonly reported items related to outcomes. Details of the intervention were poorly reported. Study
characteristics were not associated with variation in reporting.
Conclusions: The Green & Glasgow tool was useful to assess reporting of external validity items but required
tailoring to the topic area. In some public health evaluations the hypothesised impact is dependent on the
intervention effecting change, e.g. improving socio-economic conditions. In such studies data confirming the
function of the intervention may be as important as details of the components and implementation of the
intervention.
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Improving the use of research findings in policy and
practice requires, among other things, clear reporting of
external validity items [1-3]. External validity sometimes
referred to as generalisability, means the extent to which
causal inferences reported in one study can be applied to
different populations, setting, treatments and outcomes
[4,5]. For interventions this requires clear reporting of
population characteristics (including setting and reach of
the intervention), details of the intervention (including
implementation, and adaptation to local settings), out-
comes, and sustainability of the intervention and
impacts [6,7]. Improved reporting of these items can* Correspondence: hilary@sphsu.mrc.ac.uk
MRC Social & Public Health Sciences Unit, Glasgow, Scotland G12 8RZ, UK
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distribution, and reproduction in any mediumassist the reader in judging the applicability and rele-
vance of study findings to their own situation. It has
been argued that improved reporting of external validity
items may improve the usefulness and the appropriate
use of research findings, as well as potentially contribut-
ing to improved quality of available evidence [2,3].
Despite an emerging acknowledgement by publishers
of the importance of external validity, there is little clear
guidance on what should be reported to facilitate judge-
ments about external validity of study findings [6].
Within the health field much has been devoted to the
development of tools to assess internal validity, but far
less to external validity. One tool which articulates the
required external validity items has been developed by
the members of the RE-AIM team [8]. This tool is
informed by Cronbach et al’s work on generalisabilityd Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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individual patients, moderator variables, sub-popula-
tions), Treatments (variations in treatment delivery or
modality), Occasions (e.g. patterns of maintenance or re-
lapse over time in response to treatments), and Settings
(e,g, medical clinics, worksites, schools in which the
intervention is being implemented and evaluated). The
RE-AIM checklist was developed for public health inter-
ventions, specifically within the field of health promo-
tion. While acknowledging the limitations of developing
a standard tool the authors of this checklist have called
for piloting to test and refine available tools [6]. The tool
has been applied to studies of health promotion inter-
ventions [10,11], but to our knowledge, has not been
tested in the field of healthy public policy, that is non-
health sector interventions such as education, welfare,
housing, transport etc.
We used a recent systematic review of the health
impacts of housing improvements [12] to investigate
levels of reporting of external validity items using the
RE-AIM tool [8]. This brief report presents the level of
reporting and reflects on how reporting of external val-
idity might need to be adapted for use in the broader
field of healthy public policy.
Methods
The Green & Glasgow tool was tailored to meet the char-
acteristics of the studies being assessed. This required
some rewording of the original questions to improve
clarity or adapting some details of the original questions
developed by Green & Glasgow to be more appropriate
to a group of housing studies. A set of criteria to assess
the extent to which each external validity item had been
reported was developed by both authors, i.e. “large ex-
tent”, “some extent”, “unclear”, “not at all” or “not applic-
able (N/A)”. A summary of the items assessed is
provided in Table 1. The full version of the tool with the
criteria for assessment is available as Additional file 1.
Thirty nine intervention studies which had assessed
the health impacts of housing improvement and were
included in an earlier systematic review [12] were
assessed independently by two reviewers for the extent
of reporting of the external validity items detailed in the
tool, i.e. “large extent”, “some extent”, “unclear”, “not at
all” or “not applicable (N/A)”. Disagreements on the as-
sessment between the two reviewers were resolved by
discussion and where disagreements persisted the ques-
tions or assessment criteria (large extent, some extent
etc) were further clarified. Only the studies and related
papers included in the published review were included
in this assessment, this included the key paper for each
study (n = 39) plus a further 29 publications linked with
the included studies. Authors were not contacted to ob-
tain further information on external validity items.Data were extracted and entered onto a Microsoft Ac-
cess database ©. A summary score for the level of reporting
was calculated for each domain (Reach; Implementation;
Outcomes; Maintenance). The codes for each item were
converted into a numeric value (“large extent” or “some
extent”= 1 “unclear” or “not at all” or “N/A”= 0). A sub-
total score for each domain and a total score was calcu-
lated for each study. The score indicating the level of
reporting for each of the external validity items, and
summary scores for the domains were tabulated along
with key study characteristics identified in the original
systematic review, these included intervention type, con-
text, study design, and overall assessment of internal val-
idity (for details of the internal validity assessment and
definitions of the study intervention categories see the
full systematic review [12]).
Results
Application of Green & Glasgow tool
There was considerable disagreement between the two
reviewers requiring substantial iteration to clarify the
meaning and purpose of some of the external validity
items (Table 1 & Additional file 1). Three items were
particularly difficult to clarify (2, 3 & 11) and were
reworked to relate to descriptions of the study popula-
tion or setting and eligibility for the intervention. Eight
items were rephrased for clarification and/or inclusion
of terms or issues relevant to the field. Item 16 was split
into two. Five items (5, 6, 13, 14, & 15) remained un-
changed from the original tool developed by Green &
Glasgow [8]. Following these edits there was improved
agreement between the reviewers but some disagree-
ments persisted and were resolved by discussion. The
two items with greatest disagreement were 2 & 3 where
half or more of the assessments differed (50% and 68.8%
respectively). Levels of agreement were highest for items
5, 6, 15 and 16.
Reporting of external validity in housing improvement
studies
Reporting of external validity items was low across the
studies (Table 2 & Additional file 2); overall 35.3 % of
items were reported (mean 6, range 2–9, median 6).
Within each external validity domain (Reach, Implemen-
tation, Outcomes, & Maintenance) few studies reported
more than half the items either “to some extent” or “to a
large extent”. The “outcomes” domain had a greater
number of reported items among the studies (mean
items reported 49.8%); the “intervention” domain was the
most poorly reported (mean items reported 29.0%). No
item was universally reported. Item 9 & 16a were most
commonly reported. Three items were not reported in
any study: items 1, 14, and 15 (Table 2). There was little
variation in the number of reported items between
Table 1 Reworded external validity items and extent of reporting by item (n =39 studies) *
Large extent Some extent Unclear Not at all
A Population: Representativeness of target population, setting & reach of intervention
1 Are data presented on variations in participation rate in improved housing interventions
by a) setting b) delivery staff/organisations c) residents (for intervention among
general target population not study area)
0 0 0 39
2 Is the intended target audience for adoption clearly described 11 18 8 2
3 Is the intended target setting for adoption clearly described? 4 27 5 3
4 Is there analysis of the baseline socio-demographic and ‘condition tested’
(health status) of evaluation participants versus non-participants?
(relating to evaluation population only)
0 0 2 37
B Intervention: Implementation & adaptation
5 Are data presented on consistency of implementation of intervention & its different
components?
0 2 2 35
6 Are data presented on the level of training of experience required to deliver the
programme or quality of implementation by different types of staff?
0 1 1 37
7 Is information reported on whether/how the intervention is modified to
individuals/households within the study?
5 6 0 11
8 Are data presented on mediating factors or processes (mechanisms) through which
the intervention had an impact?
2 12 4 21
C Outcomes for decision making
9 Are the reported health (even if only one measure of health is comparable)
outcomes comparable to wider policy/other studies?
23 14 0 2
10 Have additional outcomes of potential adverse impacts been reported?
e.g. socio-economic impacts
4 21 1 13
11 Have authors demonstrated consideration of variation in reported health outcomes
(key outcome of interest) by population sub-groups, or intervention setting/delivery staff?
2 4 1 32
12 Is there sensitivity analysis of dose–response/threshold level required to observe
health effect (effect on key outcome of interest not proxies)?
3 4 1 31
13 Are data on costs presented? Are standard economic/accounting methods used? 2 19 0 18
D Maintenance and institutionalisation of intervention
14 Are long term effects reported?
(12 months or longer since exposure to the intervention)
10 13 4 11
15 Are data reported on the sustainability (or reinvention or evolution) of programme
implementation and intervention, at least 12 months after the formal evaluation?
0 0 0 29
16 a Is the drop-out rate/attrition reported? 19 (Yes) 10 (N/A)
16 b Are data on attrition by baseline health status of dropouts reported and are analyses
conducted of the representativeness of remaining sample at time of final follow-up
(or main follow-up time point- as appropriate)?
0 0 0 29
(10 N/A)
(adapted from Green LW, Glasgow RE. Evaluating the Relevance, Generalization, and Applicability of Research: Issues in External Validation and Translation
Methodology. Eval Health Prof 2006;29(1):126–153.)
* see Additional File 1 for full details of external validity assessment tool.
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quality studies reported more external validity items
(mean number of external validity items reported by In-
ternal Validity Grade A/B/C 6.7/5.36/5.4).
Discussion
Following adaptation and development of detailed as-
sessment criteria relevant to the studies being assessed,
the external validity tool was successfully applied to
studies of housing improvement drawing on the primary
paper and associated papers available at the time of the
original review [12]. Reporting of external validity itemswas low overall (median 35.6%) and across individual
domains in the tool. This is comparable to the level of
reporting in a group of studies of childhood obesity pre-
vention (median 34.5%) [10].
The studies we assessed represented a broad range of
study designs, contexts, and other aspects of study qual-
ity and interventions, as well as representing both pub-
lished and unpublished studies. There was no suggestion
of a link between study characteristics and reporting of
external validity. The apparent link between internal and
external validity reporting may be explained by the over-
lap in assessed items, specifically attrition and sample
Table 2 Number of external validity items reported in each study by domain
Author year Study
design
Internal
validity
grade
External validity domains (maximum possible score)
Reach &
representat’n (4)
Implementat’n &
adaptation (4)
Outcomes
(5)
Maintenance &
institutionalisat’n (4)
Total (17)
Intervention: Warmth & Energy Efficiency improvements (post 1980) (n = 19)
Heyman et al. 2010 RCT A 1 2 3 2 8
Braubach et al. 2008 CBA A 2 1 1 1 5
Howden-Chapman et al.
2008
RCT A 2 1 1 1 5
Barton et al. 2007 RCT A 2 1 3 2 8
Howden-Chapman et al.
2007
RCT A 2 0 3 1 6
Platt et al. 2007 CBA A 1 1 4 2 8
Lloyd et al. 2008 CBA B 1 0 3 2 6
Shortt et al. 2007 CBA B 2 2 2 2 8
Somerville et al. 2000 UBA B 2 1 3 1 7
Hopton et al. 1996 CBA B 2 0 2 1 5
Warm Front Study Group
2006
RC C 1 1 5 0 7
Allen 2005 a UBA C 1 1 2 2 6
Allen 2005 b UBA C 1 2 1 1 5
Health Action Kirklees 2005 R C 1 0 1 0 2
Eick et al. 2004 RCT C 2 1 4 2 9
Winder et al. 2003 UBA C 1 0 0 1 2
Caldwell et al. 2001 CBA C 2 2 3 2 9
Green et al. 1999 RC C 1 0 3 0 4
Iversen et al. 1986 CBA C 1 0 1 1 3
Mean (range) 1.47 (1–2) 0.84 (0–2) 2.37 (0–4) 1.26 (0–2) 5.95 (2–9)
Intervention: Rehousing/retrofitting +/− neighbourhood renewal (post 1995) (n = 10)
Kearns et al. 2008 CBA A 1 1 3 2 7
Thomson et al. 2007 CBA A 2 0 2 2 6
Critchley et al. 2004 CBA A 0 1 4 1 6
Thomas et al. 2005 CBA B 2 1 3 1 7
Barnes et al. 2003 CBA B 2 0 2 2 6
Evans et al. 2002 CBA B 1 0 2 0 3
Blackman et al. 2001 UBA C 2 0 2 2 6
Wells 2000 UBA C 2 0 1 2 5
Ambrose 1999 UBA C 2 1 3 2 8
Halpern 1995 XUBA C 2 1 2 1 6
Mean (range) 1.6 (0–2) 0.50 (0–1) 2.40 (1–4) 1.50 (0–2) 6 (3–8)
Intervention: Provision of basic housing needs/developing country intervention (n= 6)
Cattaneo et al. 2006 RC B 2 1 4 1 8
Choudhary et al. 2002 RC B 1 1 3 1 6
Aga Khan Health Service
2001
XCBA B 1 1 2 1 5
Spiegel et al. 2003 XCBA C 2 0 1 1 4
Aiga et al. 2002 XCBA C 1 1 3 0 5
Wolff et al. 2001 XCBA C 2 0 2 1 5
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Table 2 Number of external validity items reported in each study by domain (Continued)
Mean (range) 1.50 (1–2) 0.67 (0–1) 2.67 (1–4) 0.83 (0–1) 5.5 (4–8)
Intervention: Rehousing from slums (pre 1965) (n = 4)
Wilner et al. 1960 CBA A 2 1 3 2 8
McGonigle et al. 1936 XCBA B 2 1 4 1 8
Ferguson 1954 RC C 1 0 1 1 3
Chapin 1938 UBA C 2 1 4 2 9
Mean (range) 1.75 (1–2) 0.75 (0–1) 3.00 (2–4) 1.50 (1–2) 7.00 (3–9)
TOTAL (n = 39 studies) MEAN (range) 1.54 (0–2) 0.72 (0–2) 2.49 (0–4) 1.28 (0–2) 6.00 (2–9)
Study design: RCT: Randomised Controlled Trial; CBA: Controlled Before & After; UBA: Uncontrolled Before & After; XCBA: Cross-sectional Controlled Before & After;
XUBA: Cross-sectional Uncontrolled Before & After; RC: Retrospective controlled; R: Retrospective uncontrolled.
List of references available in reference 4 or from the author.
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tions since the original searches in 2008 will have
reported additional relevant data.
The domain relating to the intervention (items 5–8)
was least often reported; Klesges et al. reported a similar
issue [10]. While faithful replication of a novel interven-
tion may depend on detailed reporting of intervention
components and implementation [13], this may be less
important for a well established intervention, such as
housing improvements. Moreover, for complex social
interventions, such as housing improvements, data con-
firming intervention function may be of more value than
the details of intervention form [14]. Data on changes
effected by the intervention, such as improved warmth,
may be used to refine generalisable theories regarding
tackling socio-economic determinants of health even
where the specific intervention may not be widely general-
isable. Where there is evidence to support the theory that
changes in an intermediate outcome can lead to health, se-
lection and implementation of appropriate and effective
interventions to improve a named socio-economic out-
come, such as warmth, may be made locally. This issue is
of particular relevance to interventions where the hypothe-
sised health impacts are dependent on the intervention
affecting an intermediate variable, for example healthy
public policy interventions tackling socio-economic deter-
minants of health.
There is little doubt that reporting of external validity
items needs improving. However, in agreement with
Green et al, development of a standard tool may not be
appropriate [6]. In our study there was poor agreement
between the two assessors in the interpretation of the
tool. In response it was necessary to amend and clarify
meaning to allow appropriate application of the tool to
this group of studies. Specifically, aspects of mainten-
ance and reach require tailoring to the intervention,
and reporting of differential effects using sub-group
analysis will inevitably be limited where studies are typ-
ically small. Where a well established intervention like
housing improvement is being evaluated items assessingreporting of population details (namely items 2 & 3)
may require editing to clarify whether they relate to
reporting of the target population and context for the
study or the wider intervention. We chose to focus on
the study population. In addition, criteria to indicate the
extent of reporting were developed to reflect issues per-
tinent to our particular group of studies. The use of
graded criteria improves the sensitivity and interpret-
ation of the tool beyond the previous version which is
restricted to a binary assessment [10,11].
Conclusion
The RE-AIM checklist provides a useful framework to
guide authors about which external validity items to re-
port but, as indicated in earlier discussions, strict adher-
ence to the checklist may not be appropriate. Despite
this there is a need for authors to improve reporting of
items to improve the transferability of the research find-
ings. Within health public policy, the hypothesised health
impacts of interventions are often dependent on an inter-
mediate impact on a socio-economic determinant of
health. Data confirming the function of the intervention
may be as important as details of the intervention form
and may help refine generalisable theories about the
health impacts of tackling socio-economic determinants
of health.
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